Caricamento...

Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data

INTRODUCTION: Although mefloquine use is known to be associated with a risk of severe neuropsychiatric adverse reactions that are often preceded by prodromal symptoms, specific combinations of neurologic or psychiatric reactions associated with mefloquine use are not well described in the literature...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drugs R D
Autori principali: Nevin, Remington L., Leoutsakos, Jeannie-Marie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318335/
https://ncbi.nlm.nih.gov/pubmed/28063022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-016-0167-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !